Researchers identify method to diagnose cancer in patients with early onset diabetes

Patients diagnosed with pancreatic cancer can develop elevated blood sugar levels up to three years before their cancer diagnosis, according to the results of a study by Mayo Clinic researchers published the journalGastroenterology.

"Pancreatic cancer is rapidly fatal after its diagnosis, with average survival of six months," says Suresh Chari, M.D., a gastroenterologist at Mayo Clinic. "It has also been thought that its course prior to diagnosis is also rapid and that early detection is not feasible. But our studies provide hope that癌症can indeed be diagnosed at an earlier stage when it is resectable."

In the first study, researchers plotted blood sugars levels of patients with pancreatic cancer going back five years prior to diagnosis. They also plotted the blood sugars of a control group of patients who were age and gender matched to the patients with pancreatic cancer. In this group, researchers were able to show that blood sugars rise 30 to 36 months before the diagnosis of cancer.

In another group of patients and controls, researchers plotted blood sugars of nearly 600 patients with pancreatic cancer just prior to surgical removal of the cancer. Researchers grouped these patients by their tumor volume at the time of the. "In this group, we were able to show that blood sugars rise commensurate with the increasing volume of the tumor. Patients with tumors that were very small, less than one cubic centimeter in volume, had lowersugars than patients with larger tumors," Dr. Chari says.

In the second study, also published inGastroenterology, Mayo Clinic researchers describe a risk-prediction model that identifies patients with new onset diabetes that are at very high risk for developing pancreatic cancer. Researchers say the findings are significant because they represent a potential new way to diagnose pancreatic cancer at an earlier stage.

The model, called an ENDPAC score, identifies a subset of patients with new onset diabetes that have a thirty to forty-fold higher risk of having pancreatic cancer. "Among these patients, the risk of having pancreatic cancer is between four and seven percent," says Dr. Chari. "We believe that if these findings are validated,who have aand a high ENDPAC score should be thoroughly tested for pancreatic."


Explore further

Diabetes may be an early manifestation of pancreatic cancer

Journal information: Gastroenterology

Provided byMayo Clinic
Citation: Researchers identify method to diagnose cancer in patients with early onset diabetes (2018, June 21) retrieved 10 June 2021 from //www.pyrotek-europe.com/news/2018-06-method-cancer-patients-early-onset.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4shares

Feedback to editors

User comments